Naba Alsaha Medical Services Company

TADAWUL:9546.SR

65.1 (SAR) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

20242023202220212020
Revenue 194.282182.352129.684117.682115.683
Cost of Revenue 131.917108.58378.04570.89869.751
Gross Profit 62.36573.76951.63946.78345.932
Gross Profit Ratio 0.3210.4050.3980.3980.397
Reseach & Development Expenses 00000
General & Administrative Expenses 06.0554.3844.75817.226
Selling & Marketing Expenses 024.1330.4991.2531.058
SG&A 37.13430.1884.3844.75818.284
Other Expenses 00.6141.09700
Operating Expenses 37.13430.80222.23118.88918.284
Operating Income 25.2342.96728.31126.97227.648
Operating Income Ratio 0.130.2360.2180.2290.239
Total Other Income Expenses Net 1.32311.8950.6230.5560.688
Income Before Tax 26.55354.86228.93427.52828.336
Income Before Tax Ratio 0.1370.3010.2230.2340.245
Income Tax Expense 3.2742.482.0121.7011.683
Net Income 21.78452.38226.92325.82726.653
Net Income Ratio 0.1120.2870.2080.2190.23
EPS 2.074.992.562.462.54
EPS Diluted 2.074.992.562.462.54
EBITDA 37.73765.27936.03833.89934.726
EBITDA Ratio 0.1940.3580.2780.2880.3